- Home
- EVC vs CMPX Comparison
EVC vs CMPX Comparison
Compare EVC & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVC
- CMPX
- Stock Information
- Founded
- EVC 1996
- CMPX 2014
- Country
- EVC United States
- CMPX United States
- Employees
- EVC N/A
- CMPX N/A
- Industry
- EVC Broadcasting
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- EVC Industrials
- CMPX Health Care
- Exchange
- EVC Nasdaq
- CMPX Nasdaq
- Market Cap
- EVC 229.5M
- CMPX 214.6M
- IPO Year
- EVC 2000
- CMPX N/A
- Fundamental
- Price
- EVC $2.42
- CMPX $2.00
- Analyst Decision
- EVC Hold
- CMPX Strong Buy
- Analyst Count
- EVC 1
- CMPX 4
- Target Price
- EVC $1.75
- CMPX $13.75
- AVG Volume (30 Days)
- EVC 608.7K
- CMPX 1.8M
- Earning Date
- EVC 03-04-2025
- CMPX 11-12-2024
- Dividend Yield
- EVC 8.33%
- CMPX N/A
- EPS Growth
- EVC N/A
- CMPX N/A
- EPS
- EVC N/A
- CMPX N/A
- Revenue
- EVC $1,146,066,000.00
- CMPX $850,000.00
- Revenue This Year
- EVC N/A
- CMPX N/A
- Revenue Next Year
- EVC N/A
- CMPX $613.39
- P/E Ratio
- EVC N/A
- CMPX N/A
- Revenue Growth
- EVC 122.49
- CMPX N/A
- 52 Week Low
- EVC $1.33
- CMPX $0.77
- 52 Week High
- EVC $4.41
- CMPX $2.68
- Technical
- Relative Strength Index (RSI)
- EVC 49.96
- CMPX 65.48
- Support Level
- EVC $2.21
- CMPX $1.43
- Resistance Level
- EVC $2.70
- CMPX $2.68
- Average True Range (ATR)
- EVC 0.16
- CMPX 0.24
- MACD
- EVC 0.01
- CMPX 0.06
- Stochastic Oscillator
- EVC 41.84
- CMPX 46.87
About EVC Entravision Communications Corporation
Entravision Communications Corp is a global advertising solutions, media, and technology company. Its operations encompass integrated marketing and media solutions, comprised of television, radio, and digital properties and data analytics services. The company operates in television broadcasting, audio broadcasting, and digital media segments. The Company's digital segment, whose operations are located in Europe, Latin America, Asia, the United States, and Africa. The Company's television and audio operations reach and engage U.S. Hispanics in the United States.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.